- Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma
-
Kim JM
- KMID: 2463608
- J Liver Cancer.
- 2019 Sep;19(2):85-90.
- doi: 10.17998/jlc.19.2.85.
Mixed hepatocellular carcinoma and cholangiocarcinoma (HCC-CC) are rare tumors, and the risk factors associated with them are not well understood yet. Moreover, the diagnosis of mixed HCC-CC can be complicated... -
- CITED
-
- Close
- SHARE
-
- Close
- Malignant Hepatic Solitary Fibrous Tumor
-
Kim HI, In SK, Yi HS, Lee MJ, Kim HY
- KMID: 2463615
- J Liver Cancer.
- 2019 Sep;19(2):143-148.
- doi: 10.17998/jlc.19.2.143
Hepatic solitary fibrous tumors (SFTs) are mostly benign and rare because of information regarding the clinical symptoms, treatment, and prognosis of their malignant forms is currently lacking. A literature review... -
- CITED
-
- Close
- SHARE
-
- Close
- Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass
-
Kang MK, Kim MY, Kang SH, Baik SK
- KMID: 2463609
- J Liver Cancer.
- 2019 Sep;19(2):91-96.
- doi: 10.17998/jlc.19.2.91
Contrast-enhanced ultrasonography (CEUS) using microbubble ultrasonography contrast agent can show the vascular structure and unique contrast enhancement patterns of focal liver lesions, including hepatocellular carcinoma (HCC). CEUS shows three phases,... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma
-
Kim J, Yoo GS, Sinn DH, Park HC, Koh KC
- KMID: 2463614
- J Liver Cancer.
- 2019 Sep;19(2):136-142.
- doi: 10.17998/jlc.19.2.136
Proton beam therapy (PBT) is one of the advances in radiotherapy techniques, which enables dose escalation with lower probability of radiation-induced liver or gastrointestinal injuries. However, the chest wall proximal... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Onset Polymorphic Post-transplant Lymphoproliferative Disease Mimicking a Solitary Necrotizing Abscess in a Graft Liver
-
Sung PS, Lee J, Lee J, Nam HC, Bae SH, Yoon SK
- KMID: 2463619
- J Liver Cancer.
- 2019 Sep;19(2):165-170.
- doi: 10.17998/jlc.19.2.165
Although post-transplantation lymphoproliferative disease (PTLD) after liver transplantation is very rare, its prognosis is worse than that of PTLD following other types of solid organ transplantation. Here, we report a... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium
-
Park S, Yoon WS, Yim HJ, Rim CH
- KMID: 2463616
- J Liver Cancer.
- 2019 Sep;19(2):149-153.
- doi: 10.17998/jlc.19.2.149
Hepatocellular carcinoma (HCC) involving the inferior vena cava (IVC) and/or right atrium (RA) is a rare and intractable disease. A standard treatment has not been established yet, owing to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization
-
Yoon JS, Yu SJ, Lee YB, Cho EJ, Lee JH, Kim YJ, Yoon JH
- KMID: 2463618
- J Liver Cancer.
- 2019 Sep;19(2):159-164.
- doi: 10.17998/jlc.19.2.159
The treatment options available for patients with hepatocellular carcinoma (HCC) with portal vein invasion (PVI) include sorafenib, transarterial radioembolization (TARE), radiation therapy (RT), transarterial chemoembolization with RT, and proton beam... -
- CITED
-
- Close
- SHARE
-
- Close
- The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma
-
Yim SY, Lee JS
- KMID: 2463610
- J Liver Cancer.
- 2019 Sep;19(2):97-107.
- doi: 10.17998/jlc.19.2.97
The pathogenesis of hepatocellular carcinoma (HCC) is a complex process. During the last decade, advances in genomic technologies enabled delineation of the genomic landscape of HCC, resulting in the identification... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
-
Cho YY, Choi YH, Yu SJ, Cho EJ, Lee JH, Kim YJ, Yoon JH
- KMID: 2463613
- J Liver Cancer.
- 2019 Sep;19(2):128-135.
- doi: 10.17998/jlc.19.2.128
BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) is potentially nephrotoxic in chronic hepatitis B patients. Hepatocellular carcinoma (HCC) patients treated using transarterial chemoembolization (TACE) are at an increased risk of renal injury.... -
- CITED
-
- Close
- SHARE
-
- Close
- Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event
-
Kim DH, Kim M, Yim HJ, Suh SJ, Jung YK
- KMID: 2463617
- J Liver Cancer.
- 2019 Sep;19(2):154-158.
- doi: 10.17998/jlc.19.2.154
A 54-year old man diagnosed with advanced hepatocellular carcinoma began treatment with sorafenib. After 3 weeks of treatment, he complained of abdominal pain and nausea. Abdominal sonography showed multiple hepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era
-
Lee CU, Lee YS, Kim JH, Lee M, Kim S, Jung YK, Seo YS, Yim HJ, Yeon JE, Byun KS
- KMID: 2463612
- J Liver Cancer.
- 2019 Sep;19(2):117-127.
- doi: 10.17998/jlc.19.2.117
BACKGROUND/AIMS: Sorafenib is the standard treatment for patients with advanced hepatocellular carcinoma (HCC). We aimed to investigate the prognosis predictors and the role of second-line cytotoxic systemic chemotherapy (CSC) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
-
Lee HW, Cho KJ, Shin SY, Kim HY, Lee EJ, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH
- KMID: 2463611
- J Liver Cancer.
- 2019 Sep;19(2):108-116.
- doi: 10.17998/jlc.19.2.108
BACKGROUND/AIMS: Programmed death receptor 1 (PD-1) is a promising new target for treatment of patients with hepatocellular carcinoma (HCC). A high expression level of programmed death-ligand 1 (PD-L1) is a... -
- CITED
-
- Close
- SHARE
-
- Close
